A0A075B6Z3_HUMAN Loading...

T cell receptor alpha joining 6 AlphaSync

AlphaFold DB , UniProt , Accession A0A075B6Z3, Species HUMAN (Homo sapiens, Human), Gene TRAJ6, Length 21 aa.

						>A0A075B6Z3_HUMAN|A0A075B6Z3|TRAJ6
XASGGSYIPTFGRGTSLIVHP
					

Structure Viewer

Loading PAE data...

(Predicted Aligned Error values between residue pairs)

Download Structure AlphaSync Parameters PDB PAE Table

Site	Residue	pLDDT	pLDDT confidence	pLDDT₁₀	pLDDT10 confidence	SASA	SASA [Å²]	SASA₁₀	SASA10 [Å²]	RSA	RSA unformatted	RSA₁₀	RSA10 unformatted	Surface	Surface10 (not used)	Disorder (not used)	Disorder	Sec. str.	Secondary structure	Isomer	Phi (φ)	Psi (ψ)	Omega (ω)	Chi 1 (χ₁)	Chi 2 (χ₂)	Chi 3 (χ₃)	Chi 4 (χ₄)	Chi 5 (χ₅)	Tau (τ)	Contacts (colored by PAE)	Contact details
1	X	65.5	Low	80.8	Confident	129 Å²	129	113.2 Å²	113.2	100%	1.33	77%	0.774	S	S	*	*				0	143	0	0	0	0	0	0	108.2	S3	G1-S3 PolarHBondContact O-N 3.44Å
2	A	67.4	Low	82	Confident	105 Å²	105	107.8 Å²	107.8	87%	0.868	75%	0.751	S	S	*	*			trans	-52	130.6	-173.2	0	0	0	0	0	112.5	G4	A2-G4 PolarHBondContact O-N 3.35Å
3	S	72.7	Confident	83.1	Confident	123 Å²	123	119.2 Å²	119.2	86%	0.86	77%	0.768	S	S	*	*			trans	-59.4	107.3	173	-54.2	0	0	0	0	109	X1 G5	G1-S3 PolarHBondContact O-N 3.44Å; S3-G5 PolarHBondContact O-N 3.2Å
4	G	73.3	Confident	84.2	Confident	85 Å²	85	116.8 Å²	116.8	88%	0.876	78%	0.775	S	S	*	*			trans	-69.1	78.1	171.7	0	0	0	0	0	109.7	A2 S6	A2-G4 PolarHBondContact O-N 3.35Å; G4-S6 PolarHBondContact O-N 3.26Å
5	G	80.3	Confident	85	Confident	65 Å²	65	114.4 Å²	114.4	67%	0.67	76%	0.757	S	S	*	*			trans	-68.9	128.5	170	0	0	0	0	0	109	S3 Y7	S3-G5 PolarHBondContact O-N 3.2Å; G5-Y7 PolarHBondContact O-N 3.38Å; G5-Y7 VanDerWaalsContact O-N 3.15Å
6	S	83.6	Confident	85.6	Confident	112 Å²	112	113.8 Å²	113.8	78%	0.783	76%	0.755	S	S	*	*			trans	-59.7	118.2	164.3	-175.2	0	0	0	0	107.8	G4 I8	G4-S6 PolarHBondContact O-N 3.26Å; S6-I8 PolarHBondContact O-N 3.49Å
7	Y	86.1	Confident	86.1	Confident	196 Å²	196	113.6 Å²	113.6	77%	0.769	75%	0.745	S	S	*	*			trans	-78.6	112.9	175.8	178.4	-100.8	0	0	0	108.8	G5 P9	G5-Y7 PolarHBondContact O-N 3.38Å; G5-Y7 VanDerWaalsContact O-N 3.15Å; Y7-P9 HydrophobicContact CE1-CB 4.31Å
8	I	86.7	Confident	86.7	Confident	126 Å²	126	114.7 Å²	114.7	65%	0.646	74%	0.741	S	S	*	*			trans	-95.9	114.2	174.4	-58	174.7	0	0	0	107.6	S6 T10	S6-I8 PolarHBondContact O-N 3.49Å; I8-T10 PolarHBondContact O-N 3.15Å
9	P	88.8	Confident	87.1	Confident	75 Å²	75	114.5 Å²	114.5	49%	0.487	74%	0.738	S	S	.	*			trans	-64	125.1	173.1	27.3	-32.5	0	0	0	109.2	Y7 F11	Y7-P9 HydrophobicContact CE1-CB 4.31Å; P9-F11 HydrophobicContact CB-CE2 4.26Å; P9-F11 HydrophobicContact CB-CZ 4.32Å
10	T	92.6	Very high	87.4	Confident	126 Å²	126	116.5 Å²	116.5	77%	0.773	74%	0.737	S	S	*	*			trans	-108.5	130.3	175.4	-58.8	0	0	0	0	109.3	I8	I8-T10 PolarHBondContact O-N 3.15Å
11	F	92.2	Very high	87.6	Confident	103 Å²	103	120.4 Å²	120.4	45%	0.452	76%	0.763	S	S	.	*			trans	-105.5	131.4	174.4	-59.3	-78.9	0	0	0	109.8	P9 T15 L17	P9-F11 HydrophobicContact CB-CE2 4.26Å; P9-F11 HydrophobicContact CB-CZ 4.32Å; F11-T15 HydrophobicContact CB-CG2 4.16Å; F11-T15 HydrophobicContact CD1-CG2 3.79Å; F11-T15 HydrophobicContact CG-CG2 4.41Å; F11-L17 HydrophobicContact CE1-CB 4.34Å; F11-L17 HydrophobicContact CZ-CG 4.13Å; F11-L17 HydrophobicContact CZ-CD2 3.78Å; F11-L17 HydrophobicContact CZ-CD1 3.85Å; F11-L17 HydrophobicContact CZ-CB 4.13Å; F11-L17 HydrophobicContact CE2-CD2 3.85Å; F11-L17 HydrophobicContact CE2-CB 4.32Å; F11-L17 HydrophobicContact CE1-CD1 4.16Å
12	G	95.4	Very high	88.7	Confident	48 Å²	48	120 Å²	120	50%	0.495	74%	0.735	S	S	.	*			trans	-75.4	177.5	-178.8	0	0	0	0	0	113	G14 T15	G12-G14 PolarHBondContact O-N 2.82Å; G12-T15 WeakPolarHBondContact O-CB 3.48Å; G12-T15 PolarHBondContact O-N 3.02Å; G12-T15 PolarHBondContact O-OG1 3.43Å
13	R	96.4	Very high	89.8	Confident	257 Å²	257	120.8 Å²	120.8	97%	0.97	73%	0.728	S	S	*	*	T	Hydrogen-bonded Turn	trans	-61	130.5	176	-64.8	-179.8	68.4	174	1.3	109.9	T15	R13-T15 VanDerWaalsContact C-N 3.3Å
14	G	97.4	Very high	90.8	Very high	85 Å²	85	120.7 Å²	120.7	88%	0.876	72%	0.72	S	S	*	*	T	Hydrogen-bonded Turn	trans	79.9	5.2	179.5	0	0	0	0	0	114.9	G12	G12-G14 PolarHBondContact O-N 2.82Å
15	T	96.8	Very high	91.8	Very high	81 Å²	81	122.8 Å²	122.8	50%	0.497	71%	0.711	S	S	.	*			trans	-90.5	132.3	174.5	-53.3	0	0	0	0	111	F11 G12 R13	F11-T15 HydrophobicContact CB-CG2 4.16Å; F11-T15 HydrophobicContact CD1-CG2 3.79Å; F11-T15 HydrophobicContact CG-CG2 4.41Å; G12-T15 WeakPolarHBondContact O-CB 3.48Å; G12-T15 PolarHBondContact O-N 3.02Å; G12-T15 PolarHBondContact O-OG1 3.43Å; R13-T15 VanDerWaalsContact C-N 3.3Å
16	S	95.3	Very high	92.5	Very high	104 Å²	104	126.4 Å²	126.4	73%	0.727	71%	0.714	S	S	*	*			trans	-111.9	127	174.6	-60.9	0	0	0	0	110.2
17	L	93.8	Very high	93.1	Very high	112 Å²	112	127.3 Å²	127.3	59%	0.586	71%	0.709	S	S	*	*			trans	-92.6	121.5	169.3	178.9	66.5	0	0	0	108.8	F11 V19	F11-L17 HydrophobicContact CE1-CB 4.34Å; F11-L17 HydrophobicContact CZ-CG 4.13Å; F11-L17 HydrophobicContact CZ-CD2 3.78Å; F11-L17 HydrophobicContact CZ-CD1 3.85Å; F11-L17 HydrophobicContact CZ-CB 4.13Å; F11-L17 HydrophobicContact CE2-CD2 3.85Å; F11-L17 HydrophobicContact CE2-CB 4.32Å; F11-L17 HydrophobicContact CE1-CD1 4.16Å; L17-V19 HydrophobicContact CD2-CG2 4.17Å; L17-V19 HydrophobicContact CG-CG2 4.12Å
18	I	95.7	Very high	93.6	Very high	132 Å²	132	122.4 Å²	122.4	68%	0.677	71%	0.705	S	S	*	*			trans	-107	122.5	174.4	-55.7	171.9	0	0	0	107.2
19	V	94.5	Very high	94.2	Very high	111 Å²	111	122.2 Å²	122.2	67%	0.673	71%	0.709	S	S	*	*			trans	-110.2	124.1	175.6	-177.8	0	0	0	0	108.2	L17	L17-V19 HydrophobicContact CD2-CG2 4.17Å; L17-V19 HydrophobicContact CG-CG2 4.12Å
20	H	93.1	Very high	94.6	Very high	155 Å²	155	126.1 Å²	126.1	72%	0.718	73%	0.728	S	S	*	*			trans	-93.9	134	165.9	-60.8	173.9	0	0	0	107.6
21	P	92.1	Very high	94.8	Very high	199 Å²	199	126.1 Å²	126.1	100%	1.292	72%	0.724	S	S	*	*			trans	-54	0	173.5	-23.2	33.2	0	0	0	113

Retrieved 21 of 21 residues in 11.6 ms (Link to these results)

U.S. Privacy Notice - Disclaimer / Registrations / Copyright Statement - Linking Policy - Notice of Privacy Practices (HIPAA) - Notice of Non‑Discrimination
© Copyright 2026 St. Jude Children's Research Hospital, a not-for-profit, section 501(c)(3).